-
61
Table S5 from Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
62
Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
63
Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
64
Figure 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
65
Table 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
66
Supplementary Figure S5 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros...
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
67
Supplementary Figure S1 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros...
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
68
Supplementary Figure S4 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros...
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
69
Supplementary Figure S2 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros...
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
70
Supplementary Figure S3 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Pros...
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
71
Supplementary Table S3 from Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
72
Table S7 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
73
Table S3 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
74
Table S2 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
75
Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
76
Table S8 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
77
Table S5 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
78
Table S4 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
79
Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Can...
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”
-
80
Supplementary Table S2 from Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation
Almmustuhtton 2025Fáttát: “…Cancer Detection and Diagnosis…”